In addition, studies have shown that drug resistance‐related genes like Y‐box binding protein 1 (YB‐1) and forkhead box M1 (FoxM1) promote sorafenib resistance in HCC cells by inducing AKT1 activity.22, 23. Here, AKT1 is linked to hepatocellular carcinoma.